| Dr John Joseph Michalisin Jr, MD | |
|
10 Union Sq E, Suite 2q/2r, New York, NY 10003-3314 | |
| (212) 844-8930 | |
| Not Available |
| Full Name | Dr John Joseph Michalisin Jr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 10 Union Sq E, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275846396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 267338 (New York) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 267338 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
Researchers at Carnegie Mellon University have developed a new dynamic statistical model to visualize changing patterns in networks, including gene expression during developmental periods of the brain.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
Children who overreact to stressors may be at risk of becoming overweight or obese, according to researchers at Penn State and Johns Hopkins University.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851456701 PECOS PAC ID: 1355232422 Enrollment ID: O20040329001569 |
News Archive
Researchers at Carnegie Mellon University have developed a new dynamic statistical model to visualize changing patterns in networks, including gene expression during developmental periods of the brain.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
Children who overreact to stressors may be at risk of becoming overweight or obese, according to researchers at Penn State and Johns Hopkins University.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Researchers at Carnegie Mellon University have developed a new dynamic statistical model to visualize changing patterns in networks, including gene expression during developmental periods of the brain.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
Children who overreact to stressors may be at risk of becoming overweight or obese, according to researchers at Penn State and Johns Hopkins University.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Joseph Michalisin Jr, MD 10 Union Sq E, Suite 2q/2r, New York, NY 10003-3314 Ph: (212) 844-8930 | Dr John Joseph Michalisin Jr, MD 10 Union Sq E, Suite 2q/2r, New York, NY 10003-3314 Ph: (212) 844-8930 |
News Archive
Researchers at Carnegie Mellon University have developed a new dynamic statistical model to visualize changing patterns in networks, including gene expression during developmental periods of the brain.
Treatment for individuals who experience psychosis, such as hallucinations and delusions as a result of a psychiatric illness, can be targeted to a specific structural mutation, according to a study published by researchers from McLean Hospital and other institutions in the journal Biological Psychiatry.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
Children who overreact to stressors may be at risk of becoming overweight or obese, according to researchers at Penn State and Johns Hopkins University.
› Verified 9 days ago
Dr. Jason H Epstein, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 423 E 23rd St, New York, NY 10010 Phone: 212-686-7500 | |
Dr. Aisha Baqai, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 525 E 68th St # M-312, New York, NY 10065 Phone: 212-746-2941 Fax: 212-746-8713 | |
Dr. Donna Bracken, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 506 Malcolm X Blvd, New York, NY 10037 Phone: 212-939-1000 | |
Michael Newman Singleton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 535 E 70th St, New York, NY 10021 Phone: 212-606-1036 | |
Dr. Thor Lidasan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 462 1st Ave # A-560, New York, NY 10016 Phone: 212-562-2300 Fax: 212-562-3486 | |
Kenneth H Jacobson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-5072 | |
Roni Mendonca, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Metropolitan Hospital, 1901 1st Ave 5 South 2, New York, NY 10029 Phone: 212-423-7095 |